Ironwood Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRWD research report →
Companywww.ironwoodpharma.com
Ironwood Pharmaceuticals, Inc. , a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union.
- CEO
- Thomas A. McCourt
- IPO
- 2010
- Employees
- 253
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $645.28M
- P/E
- 6.27
- P/S
- 1.78
- P/B
- -2.95
- EV/EBITDA
- 4.97
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.62%
- Op Margin
- 55.83%
- Net Margin
- 28.26%
- ROE
- -38.88%
- ROIC
- 29.97%
Growth & Income
- Revenue
- $296.15M · -15.72%
- Net Income
- $24.02M · 2629.20%
- EPS
- $0.15 · 2627.27%
- Op Income
- $118.76M
- FCF YoY
- 22.83%
Performance & Tape
- 52W High
- $5.78
- 52W Low
- $0.55
- 50D MA
- $3.78
- 200D MA
- $3.00
- Beta
- 0.30
- Avg Volume
- 2.83M
Get TickerSpark's AI analysis on IRWD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 17, 26 | DENNER ALEXANDER J | sell | 6,725,000 |
| Mar 17, 26 | DENNER ALEXANDER J | sell | 5,800 |
| Mar 13, 26 | DENNER ALEXANDER J | other | 4,451 |
| Mar 10, 26 | John Minardo | other | 136,612 |
| Mar 10, 26 | Martini Gregory S. | other | 136,612 |
| Mar 10, 26 | Gaskins Tammi L | other | 136,612 |
| Mar 10, 26 | Shetzline Michael | other | 136,612 |
| Mar 10, 26 | Silver Ronald | other | 163,934 |
| Mar 10, 26 | MCCOURT Thomas A | other | 409,836 |
| Feb 23, 26 | John Minardo | sell | 17,439 |
Our IRWD Coverage
We haven't published any research on IRWD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IRWD Report →